Literature DB >> 26932883

[An introduction of surgical update in 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer].

X B Lan1, H Zhang.   

Abstract

Both of the incidences of thyroid nodules and thyroid cancer have increased in recent years, which have attracted extensive attention. Surgical treatment plays an important role on the management of thyroid nodules and differentiated thyroid cancer (DTC). Usually patients will have an excellent prognosis after standard surgery, in the meantime, they will suffer from wrongly performed operation, which induces bad outcomes for the patients and their families both physically and psychologically, as well as economic burden. There are many guidelines concerning the suitable treatment for thyroid nodules and thyroid cancer all over the world, and the most famous one is American Thyroid Association (ATA) Management Guidelines for Patients with Thyroid Nodules and DTC in 1996 and the revised version in 2009. Over the past several years, there have been many advances in both the diagnosis and treatment of thyroid nodules and DTC. As a result, the ATA had updated the guidelines in 2015. In this article, we introduced the surgical update in 2015 ATA management guidelines for adult patients with thyroid nodules and DTC compared to the 2009 version, which consists of appropriate operation for thyroid nodules and DTC, operation for pregnant women with DTC, lymph node dissection, completion thyroidectomy, appropriate perioperative approach to voice and parathyroid, and surgery for advanced cancer.

Entities:  

Mesh:

Year:  2016        PMID: 26932883     DOI: 10.3760/cma.j.issn.0529-5815.2016.03.004

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  5 in total

1.  Non-invasive diagnosis of papillary thyroid microcarcinoma: a NMR-based metabolomics approach.

Authors:  Jinghui Lu; Sanyuan Hu; Paolo Miccoli; Qingdong Zeng; Shaozhuang Liu; Lin Ran; Chunxiao Hu
Journal:  Oncotarget       Date:  2016-12-06

2.  Time trend analysis of thyroid cancer surgery in China: single institutional database analysis of 15,000 patients.

Authors:  Chengqiu Sui; Nan Liang; Rui Du; Qiao He; Daqi Zhang; Fang Li; Yantao Fu; Gianlorenzo Dionigi; Hui Sun
Journal:  Endocrine       Date:  2020-03-02       Impact factor: 3.633

3.  Thyroid cancer MR molecular imaging via SHP2-targeted nanoparticles.

Authors:  ZhongQian Hu; JiaLe Qin; TianKuan Li; JinHe Guo
Journal:  Int J Nanomedicine       Date:  2019-09-10

4.  Lymph node characteristics of 6279 N1 differentiated thyroid cancer patients.

Authors:  Chengqiu Sui; Qiao He; Rui Du; Daqi Zhang; Fang Li; Gianlorenzo Dionigi; Nan Liang; Hui Sun
Journal:  Endocr Connect       Date:  2020-01-01       Impact factor: 3.335

5.  Meis homeobox 2 (MEIS2) inhibits the proliferation and promotes apoptosis of thyroid cancer cell and through the NF-κB signaling pathway.

Authors:  Xiaohui Wen; Mingyu Liu; Jingyan Du; Xun Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.